Home / Hedge fund growth to favour multi-strategy products

Hedge fund growth to favour multi-strategy products

Hedge funds should see good fund flows in 2015, although macro and managed-futures strategies are likely to lag behind multi-strategy funds as preferred options for institutional investors, according to a report by eVestment.

The report, (view here) says that, barring an unexpected global or financial event, global flows into hedge funds will be between US$90-110 billion, which will keep the industry above the US$3 trillion milestone of assets under management that it passed last year.

eVestment predicts further flows into equity strategies, although they are likely to be lower than last year’s 8.6 per cent growth rate. Favoured strategies are event and activist funds.

  • In the fixed income space, there will also be a further move out the risk curve, with investors favouring distressed debt and special situations.

    With multi-strategy funds, the report says that their diversity makes them “a natural preference for traditional dollars rotating into the hedge fund industry and allocations at the rate seen in 2014 will likely continue”.

    The drivers of the growth for hedge funds are concerns about equity market valuations, especially as the US market has risen about 50 per cent in two years, and continued low interest rates.

    Investor Strategy News


    Related
    ‘Bubble thinking’: Howard Marks on market blow-ups

    Higher starting valuations usually lead to lower returns, but the most important part of a bubble is “highly skewed psychology” – and investors remain anchored to sanity.

    David Chaplin | 10th Jan 2025 | More
    ‘Martian real estate’ and bittersweet farewells: ISN’s top 10 stories of 2024

    This year’s top 10 stories included a peek into AustralianSuper’s international equities build out in London, AMP’s move to slash employee benefits, and plenty of hard-hitting analysis of the issues that matter in institutional investment. But the real story is how readers helped shape all of that coverage.

    Lachlan Maddock | 18th Dec 2024 | More
    ‘Nothing will stop me’: Stuart Place rides 15,451 km for son’s rare disease

    Orbis’ Stuart Place is riding from Melbourne to the Moon and Back to fund a treatment for the “monster of a disease” that his youngest son was born with. The investment industry is rallying behind him.

    Lachlan Maddock | 18th Dec 2024 | More
    Popular